Quick Answer
TENAX THERAPEUTICS, INC. reported Stockholders Equity of $97.07 million for fiscal year 2025.
TENAX THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $97.07M | +5.5% |
| 2024 | $91.99M | +1036.0% |
| 2023 | $8.10M | +442.4% |
| 2022 | $1.49M | -64.8% |
| 2021 | $4.24M | -8.2% |
| 2020 | $4.63M | +22.6% |
| 2019 | $3.77M | -68.0% |
| 2018 | $11.77M | +32.5% |
| 2017 | $8.88M | -48.2% |
| 2016 | $17.14M | -71.6% |
| 2015 | $60.42M | -14.2% |
| 2015 | $70.43M | -15.0% |
| 2014 | $82.86M | +4759.9% |
| 2013 | -$1.78M | -413.8% |
| 2012 | -$346.0K | +90.7% |
| 2011 | -$3.72M | -275.1% |
| 2010 | $2.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $96.21M | -1.0% | -6.9% |
| June 30, 2025 | $103.33M | +1064.2% | -5.5% |
| March 31, 2025 | $109.29M | +779.3% | +18.8% |
| December 31, 2024 | $91.99M | +1036.0% | -5.4% |
| September 30, 2024 | $97.22M | +761.4% | +995.3% |
| June 30, 2024 | $8.88M | -32.9% | -28.6% |
| March 31, 2024 | $12.43M | -12.9% | +53.5% |
| December 31, 2023 | $8.10M | +442.5% | -28.3% |
- TENAX THERAPEUTICS, INC. showed an increase of +5.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, TENAX THERAPEUTICS, INC.’s stockholders equity has grown by 4463.7% (from $2.13 million to $97.07 million).
- The most recent figure is from TENAX THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: